What does a Pap smear result showing partially obscuring thick areas indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Understanding Pap Smear Results Showing "Partially Obscuring Thick Areas"

When a Pap smear report indicates "partially obscuring thick areas are present," this means that the sample has some areas where excessive thickness, inflammation, blood, or other elements are making it difficult to clearly visualize all the cells, but the specimen is still considered adequate for evaluation.

What This Finding Means

  • "Partially obscuring thick areas" is a comment on specimen adequacy, not a diagnosis of any cervical abnormality 1
  • This finding falls under the Bethesda System for reporting cervical cytology, which standardizes terminology for Pap smear results 2, 3
  • The specimen is still considered "satisfactory for evaluation" despite these limitations, meaning that sufficient cells are visible to make an assessment 1, 2
  • Common causes of partially obscuring thick areas include:
    • Excessive inflammation or white blood cells 2, 4
    • Blood that partially obscures the view of cells 4
    • Technical issues during sample collection or preparation 4
    • Poor fixation or staining of the specimen 4

Clinical Significance

  • This finding alone does not indicate cervical pathology or cancer 5
  • It is a quality indicator that alerts the clinician to potential limitations in the interpretation 1, 4
  • The presence of partially obscuring elements may slightly increase the risk of missing subtle cellular abnormalities 6, 4
  • This is different from an "unsatisfactory" specimen, which would require immediate repeat testing 2, 4

Recommended Follow-Up

  • If the Pap smear is otherwise normal (negative for intraepithelial lesion or malignancy):

    • Follow routine screening guidelines appropriate for the patient's age and risk factors 7, 8
    • No immediate repeat testing is necessary solely due to this finding 2
  • If inflammation is noted along with partially obscuring thick areas:

    • Consider treating any underlying infection if clinically indicated 2, 6
    • In cases of severe inflammation with reactive cellular changes, a repeat Pap smear in 3 months may be considered 2, 8
  • If any epithelial cell abnormalities are noted despite the partially obscuring areas:

    • Follow appropriate guidelines for the specific abnormality detected (e.g., ASC-US, LSIL, HSIL, or AGC) 7, 1
    • Women with abnormal findings should be referred for colposcopy and directed biopsy as indicated 7, 9

Special Considerations

  • For HIV-infected women:

    • More vigilant follow-up is recommended due to higher risk of cervical abnormalities 7
    • HIV-infected women have 10-11 times higher risk of abnormal cervical cytology compared to the general female population 7, 9
    • Consider more frequent screening if there is a history of abnormal Pap tests 7
  • For pregnant women:

    • Partially obscuring thick areas may be more common due to physiologic changes 2
    • Routine prenatal care should include Pap smear testing 2

Tips for Future Pap Smears

  • To reduce the likelihood of partially obscuring thick areas in future tests:

    • Avoid scheduling Pap smears during menstruation 2
    • If severe cervicitis is present, consider treating before obtaining the Pap smear 2
    • Ensure proper sample collection technique and fixation 4
  • Patient education is important:

    • Explain that this finding does not indicate cancer or precancer 5
    • Emphasize the importance of regular screening according to guidelines 2, 5

Remember that the primary purpose of cervical cancer screening is to identify precancerous lesions before they progress to cancer 5. A finding of "partially obscuring thick areas" is a technical comment about the sample quality rather than a diagnosis of disease.

References

Guideline

cervical cancer screening.

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

Guideline

Management of Atrophic Pattern Predominantly Basal Cells on Pap Smear

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Causes and frequency of unsatisfactory cervicovaginal smears].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti, 2011

Guideline

sexually transmitted diseases treatment guidelines, 2010.

MMWR Recommendations and Reports, 2010

Guideline

Clasificación y Manejo de Resultados de Citología Cervical

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Can a 99213 (Current Procedural Terminology) code be used for a routine Pap smear visit for a female patient of reproductive age with no previous history of cervical cancer or abnormal Pap smear results?
Can an Intrauterine Device (IUD) be placed if a Pap test result is positive for Atypical Squamous Cells of Undetermined Significance (ASCUS)?
How to perform a Pap (Papanicolaou) smear at the vaginal cuff?
What is the appropriate ICD-10 code and next steps for a female patient with an abnormal Pap (Papanicolaou) smear, and when should she be referred to a gynecological specialist?
In a 47‑year‑old woman with a friable cervix, recent menstruation, negative STD tests, and a satisfactory but scant Pap smear showing blood and inflammation but no intraepithelial lesion, what is the recommended next step in management?
Is there a correlation between hypogonadism and hyperparathyroidism?
What vitamin levels should be checked in a female patient on Zepbound (tirzepatide) with significant weight loss and fatigue due to reduced food intake?
What is the next step for a patient with irritative voiding symptoms after BCG (Bacillus Calmette-Guérin) treatment, granulomatous cystitis on biopsy, and currently on oxybutynin (Ditropan) and pyridium (Phenazopyridine)?
What dose of iron bisglycinate (Iron(II) glycinate) provides 150-200 mg of elemental iron?
How to manage low libido in patients with hyperparathyroidism?
Does taking Mucinex (Guaifenesin) help with conception by thinning out cervical mucus?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.